An interventional study of Milk Consumption (Cow's, Lactose-Free Cow's, Goat's, and Donkey's Milk). in Diabetes (Insulin-requiring, Type 1 or Type 2), sponsored by Pontificia Universidad Catolica de Chile. Completed at 1 site in Chile. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Pontificia Universidad Catolica de Chile · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Diabetes Mellitus, Type 1 with a site in Chile — none open to participants now, 1 under way, none of them phase 3. Diabetes Mellitus, Type 1 · Chile.
Among the 10 studies in Diabetes Mellitus, Type 1 with a site in Chile, this one is the 9th largest by enrollment, is the only one that started in 2023, is one of 3 with no phase, and was the 10th registered.
3,755 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.
Browse Diabetes Mellitus, Type 1 studies →None of the 10 studies in Diabetes Mellitus, Type 1 with a site in Chile is open now. The open studies under Diabetes Mellitus, Type 1, anywhere →
Of the 415 Diabetes Mellitus, Type 1 studies recruiting now, 129 (31%) set no upper age limit and 260 (63%) stop at 75 or younger; 187 take children under 18; 65 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2006; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 14 is below the median of 40 across 2,821 interventional studies indexed under Diabetes Mellitus, Type 1.
Median enrollment 59 across the 10 interventional studies. Of the 7 that completed or were terminated, 4 (57%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 10 have an industry lead sponsor. The 8 most frequent:
Pontificia Universidad Catolica de Chile is the lead sponsor of 225 studies on the registry; 59 are open to participants now.
Pontificia Universidad Catolica de Chile has 1 study filed under Diabetes Mellitus, Type 1 — fewer than ten, so there is no comparison to draw.
1 of the studies in Diabetes Mellitus, Type 1 with a site in Chile that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06812988SanofiTreatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule | 2027-04-29 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Diabetes Mellitus, Type 1 with a site in Chile, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Only 2 out of 10 individuals meet the recommended dairy intake. This may be partly attributed to the high prevalence of lactose intolerance, which has led to an increased demand for lactose-free products. However, lactose-free milk contains high levels of its constituent monosaccharides (glucose and galactose), which increase its glycemic index (GI). GI is a key parameter in the dietary management of individuals with type 1 diabetes (T1D), as it helps guide food selection to achieve better glycemic control.
Emerging types of milk available on the market, such as goat and donkey milk, are naturally low in lactose and may represent lower-GI alternatives to lactose-free cow's milk. However, neither their GI nor their glycemic response in individuals with T1D has been evaluated.
Objective: To compare the GI in healthy individuals and the glycemic response in individuals with T1D following the consumption of donkey, goat, and cow's milk, with and without lactose.
Hypothesis: Donkey and goat milk have a lower GI in healthy individuals and elicit a lower glycemic response in individuals with T1D compared with regular and lactose-free cow's milk.
Methods: The GI in healthy individuals and the glycemic response in individuals with T1D will be determined following the consumption of regular cow's milk, lactose-free cow's milk, goat milk, and donkey milk, according to ISO 26642:2010. Each milk sample will provide 25 g of available carbohydrates and will be compared with a reference food (glucose solution).
Expected Results: Emerging types of milk are expected to have a lower GI than lactose-free cow's milk. Additionally, goat and donkey milk consumption is expected to result in a lower glycemic response than lactose-free cow's milk in individuals with T1D.
I. Background and Rationale
Milk production currently faces several challenges, one of which is the emergence of plant-based dairy substitutes in the market. These products target consumers seeking alternatives due to personal beliefs, preferences, or specific nutritional needs, many of which arise from food allergies or intolerances.
In this context, several unconventional or emerging dairy alternatives are available. Milk from species such as goats and donkeys represents an opportunity due to their nutritional profiles and the increasing availability of these products in the domestic market, both as fluid milk and in powdered forms or derived products such as yogurt, among others. These alternatives may help meet nutritional requirements when cow's milk cannot be consumed.
The National Food Consumption Survey (ENCA 2010-2011) found that only 23% of the Chilean population meets the recommendation of consuming three servings of dairy products per day, as established by the Food-Based Dietary Guidelines in Chile (1). This is despite worldwide recommendations highlighting the health benefits of dairy consumption, particularly for bone health and, additionally, for promoting cardiovascular health and preventing non-communicable chronic diseases (2).
One of the main reasons for seeking alternatives to cow's milk is lactose intolerance. This condition refers to the inability to digest lactose, the main sugar in milk, due to a deficiency of the enzyme lactase in the small intestine. Globally, approximately 50% of adults experience this condition (3). Lactase deficiency may be complete or partial, resulting in varying degrees of lactose intolerance. Consequently, the national dairy industry has developed lactose-free milk and dairy products.
Goat's milk is recognized for its health-promoting properties, particularly its nutritional composition. It is considered free of allergens, has a lower lactose content than cow's milk, and provides a higher fat content. It contains approximately 3% total protein, 3.5% fat, and 4% total carbohydrates, with reported lactose concentrations ranging from 3.2 to 5.0 g per 100 mL of fresh milk (4).
On the other hand, donkey's milk has historically been used as nutritional support in cases of malnutrition due to its immunoglobulin and lysozyme content, which contribute to immune system protection. Donkey's milk contains approximately 2% protein, 0.25% total fat, 6% total carbohydrates, and between 5.8 and 7.4% lactose. Donkey's milk is characterized by its similarity to human breast milk. Like human milk, donkey's milk contains very little casein (a protein that is difficult to digest) and is rich in lactalbumins (5).
Dairy products (milk and its derivatives) are considered foods with high nutritional density, as they are important sources of micronutrients, as well as proteins, fats, and carbohydrates. Lactose is the predominant carbohydrate naturally present in milk and has a relatively stable concentration (6). This disaccharide is hydrolyzed in the small intestine into D-glucose and D-galactose through the action of the enzyme lactase-phlorizin hydrolase (7). However, the prevalence of lactose intolerance is high, exceeding 50% (3), which could partly explain the low consumption of milk in our country. Accordingly, the market for lactose-free cow's milk has experienced substantial growth and continues to expand (8).
One of the many advantages of milk consumption is that milk is considered a food with a low glycemic index (GI). GI refers to the ability of the digestible carbohydrates in a given food to raise blood glucose levels (9). In this regard, the effect of carbohydrates on blood glucose levels varies according to their structure and the composition of the accompanying diet. Postprandial glycemic responses vary considerably depending on the type of carbohydrate consumed (10).
It is worth noting that lactose-free products available on the market are obtained through enzymatic treatment during industrial processing, using lactase to hydrolyze lactose into its constituent monosaccharides, D-glucose and D-galactose (11). This is an important consideration because the GI of lactose is 43 ± 0, whereas that of glucose is 107 ± 7 (12). Therefore, in lactose-free milk, carbohydrates are present as monosaccharides, which are absorbed and transported into the bloodstream, rapidly increasing blood glucose concentrations (13).
In previous studies conducted at the Nutritional Biochemistry Laboratory of the Department of Nutrition, University of Chile, we observed that lactose-free cow's milk has a higher GI than regular cow's milk, also presenting high variability in the data (81.2 ± 147.9 versus 45.7 ± 55.1, respectively) (14).
Type 1 diabetes (T1D) is a condition characterized by an absolute deficiency in insulin secretion by pancreatic beta cells. Diagnostic confirmation is based on blood glucose measurements: random blood glucose levels above 200 mg/dL in the presence of associated symptoms, two fasting blood glucose measurements above 126 mg/dL, or a 2-hour oral glucose tolerance test result above 200 mg/dL (15).
Treatment is based on insulin therapy and dietary management. Insulin therapy aims to replicate endogenous insulin secretion through basal and postprandial insulin administration. Following the implementation of Law No. 20,850 in 2015, individuals with type 1 diabetes in Chile are guaranteed access to a continuous subcutaneous insulin infusion system, also known as an insulin pump (IP). In addition to administering insulin, this device incorporates a sensor that allows real-time monitoring and interpretation of blood glucose levels (16). This makes it possible to identify the glycemic response of individuals with type 1 diabetes following the consumption of specific amounts of carbohydrates.
Furthermore, dietary recommendations focus on carbohydrate counting as a strategy for meal planning in these individuals, with the aim of achieving better glycemic control (17). Therefore, the use of GI as a tool for glycemic control is essential in the dietary management of individuals with type 1 diabetes (18).
The present research project aims to generate further evidence regarding the effects of consuming milk with different lactose contents on GI in healthy individuals and on glycemic response (GR) in individuals with type 1 diabetes, together with the chemical and sensory characterization of emerging milk alternatives (goat's and donkey's milk).
It is expected, for example, that goat's and donkey's milk will produce lower GI and GR values compared with regular and lactose-free cow's milk. However, evidence regarding the GI and GR of different milk alternatives with low lactose content remains limited. Furthermore, no studies have evaluated differences in postprandial blood glucose levels following the consumption of milk with different lactose contents in individuals with type 1 diabetes.
The information obtained from this study will provide baseline data to promote the consumption of these milk alternatives and support the development of new dairy products derived from them.
Additionally, to date, there is limited or no information regarding the sensory acceptability of emerging dairy alternatives (donkey's and goat's milk) compared with traditional cow's milk. Since the consumption of these milk alternatives is being promoted, it is essential to obtain validated evidence regarding their effects on the human body.
III. Working Hypothesis
Donkey's and goat's milk have a lower glycemic index (GI) in healthy individuals and elicit a lower glycemic response (GR) in individuals with type 1 diabetes compared with regular and lactose-free cow's milk.
IV. General and Specific Objectives
General Objective:
To compare the glycemic index (GI) in healthy individuals and the glycemic response in individuals with type 1 diabetes following the consumption of donkey's, goat's, and cow's milk, with and without lactose.
Specific Objectives:
SO1: To select and chemically characterize fluid donkey's, goat's, and cow's milk, with and without lactose.
SO2: To evaluate the GI of milk (regular cow's milk, lactose-free cow's milk, donkey's milk, and goat's milk) in healthy individuals.
SO3: To compare the postprandial glycemic response following the consumption of isoglucidic milk samples with different lactose contents (regular cow's milk, lactose-free cow's milk, donkey's milk, and goat's milk) in individuals with type 1 diabetes.
SO4: To evaluate the acceptability and sensory attributes of donkey's, goat's, and cow's milk, with and without lactose, through sensory analysis.
V. Methodology
Objective 1: Selection and chemical characterization of fluid donkey's, goat's, and cow's milk, with and without lactose, for use in the experimental trials.
A comparative analysis will be conducted of commercially available fluid milk products, including donkey's and goat's milk, considering products with the appropriate certifications to ensure their suitability for human consumption. Regular and lactose-free cow's milk sourced from southern Chile will be used as controls to ensure the inclusion of milk from pasture-raised cows.
Chemical characterization will include the analysis of lactose, fat, protein, and total solids content using an infrared method (MilkoScan).
The fatty acid profile of the four milk samples under study will be determined by gas chromatography (GC).
These analyses will be conducted at the INIA Remehue laboratories.
Objective 2: Evaluation of the GI of milk with different lactose contents (regular cow's milk, lactose-free cow's milk, donkey's milk, and goat's milk) in healthy individuals.
Study design:
A randomized crossover experimental study will be conducted to determine the GI of four types of milk (regular cow's milk, lactose-free cow's milk, donkey's milk, and goat's milk) in 10 healthy individuals.
Inclusion criteria will be as follows: age between 20 and 45 years, body mass index (BMI) between 18.5 and 24.9 kg/m², absence of non-communicable chronic diseases, and absence of milk allergies and/or intolerances.
To assess eligibility, an initial questionnaire will be administered to collect information regarding date of birth, medication use, allergies, and food intolerances. Weight and height will be measured, a biochemical profile will be assessed, and an oral glucose tolerance test will be performed to confirm that participants are healthy.
Recruitment will be carried out through social media.
Protocol:
Participants will be required to attend the Department of Nutrition, 3rd floor, Sensory Analysis Laboratory, on six mornings separated by a minimum of one day and a maximum of four days.
They will be instructed to refrain from intense physical activity for at least one day prior to the measurements and to maintain their usual dietary patterns.
The GI will be determined according to ISO 26642:2010.
Briefly, after an overnight fast of 8-12 hours, two capillary blood samples will be collected from participants using an Accu-Chek® Instant device. Participants will be randomly assigned to receive 25 g of available carbohydrates in the form of 25 g of anhydrous glucose (in solution) on two separate occasions, as well as 25 g of available carbohydrates from each of the following milk samples: regular cow's milk, lactose-free cow's milk, donkey's milk, and goat's milk (approximately 300 mL of each type of milk).
The samples must be consumed within a period not exceeding 15 minutes.
Capillary blood samples will be collected before milk consumption, every 15 minutes during the first hour, and then every 30 minutes until the completion of the 2-hour period (19).
GI determination:
The glycemic index of each milk sample will be determined by dividing the incremental area under the curve (iAUC) for each milk sample by the mean iAUC obtained after glucose consumption, multiplied by 100.
Objective 3: Comparison of the postprandial glycemic response following the consumption of isoglucidic milk samples with different lactose contents (regular cow's milk, lactose-free cow's milk, donkey's milk, and goat's milk) in individuals with type 1 diabetes.
Study design:
A randomized crossover experimental study will be conducted to evaluate the glycemic response (GR) of 30 adults with type 1 diabetes treated with an insulin pump (IP) at the UC CHRISTUS Health Network.
The sample size was calculated based on the assumption that following the consumption of lactose-containing milk, blood glucose levels would increase by at least 25% compared with blood glucose levels following the consumption of lactose-free milk.
Using an alpha level of 0.05, a statistical power of 80%, and an estimated variability of 20, a minimum total sample size of 30 volunteers was determined.
Individuals receiving care for type 1 diabetes within the UC CHRISTUS Health Network will be invited to participate in the study via email.
Inclusion criteria:
Individuals with type 1 diabetes.
Insulin pump users.
Age over 18 years.
No physical exercise during the 24 hours preceding the study.
No active insulin remaining from a previous bolus (participants must be fasting or must have eaten breakfast sufficiently early).
Exclusion criteria:
Food allergies and/or intolerances to the products under study.
Poor glycemic control.
Gastrointestinal symptoms following food consumption.
Malabsorptive diseases (Crohn's disease or active celiac disease).
Short bowel syndrome.
Once patients agree to participate in the study and sign the informed consent form, they will be scheduled for an in-person appointment at the San Joaquín Medical Center of the UC CHRISTUS Health Network.
Protocol:
Meeting at the San Joaquín Medical Center, UC CHRISTUS Health Network
During this meeting, participants will:
Receive five 200-mL milk cartons. One carton of regular cow's milk will be provided to validate the insulin pump. The remaining four cartons will be used to evaluate the glycemic response following consumption of the following milk samples:
Regular cow's milk.
Lactose-free cow's milk.
Donkey's milk.
Goat's milk.
i. Participants must fast for 4 hours.
ii. Insulin pump validation: A control test using regular cow's milk (containing lactose) will be performed to validate the insulin pump. In the event of hyperglycemia, the insulin pump settings will be adjusted, and the test with lactose-containing milk will be repeated to assess the correction adjustment.
The following blood glucose ranges will be considered:
Euglycemia: 70-180 mg/dL.
Mild hyperglycemia: 181-250 mg/dL.
Severe hyperglycemia: >250 mg/dL.
d. Receive instructions for the days on which the remaining milk samples must be consumed:
i. Before consuming the milk, participants must undergo a 4-hour fast to ensure that there is no active insulin.
ii. Each milk sample must be consumed at home, with a one-week interval between samples.
Week 1: Regular cow's milk.
Week 2: Lactose-free cow's milk.
Week 3: Donkey's milk.
Week 4: Goat's milk.
iii. To ensure adequate monitoring, participants will be asked to measure capillary blood glucose levels before milk consumption and subsequently at 1, 3, and 4 hours after consumption (up to 4 hours following milk administration, corresponding to the half-life of insulin). A minimum fasting period of 4 hours will be required.
e. Receive a schedule outlining the milk consumption dates and capillary blood glucose measurements.
f. Be scheduled for an online meeting via Zoom to obtain blood glucose data through insulin pump monitoring.
During this meeting, blood glucose data will be obtained through insulin pump monitoring. Glucose values will be recorded using the insulin pump sensor readings for the 4-hour period following milk consumption.
Objective 4: Evaluation of the acceptability and sensory attributes of donkey's, goat's, and cow's milk, with and without lactose, through sensory analysis involving consumer and trained panels.
Sensory characterization of the milk samples will be performed through sensory analysis using a trained panel (10-12 panelists).
Trained panel:
INIA has a sample preparation room, individual sensory evaluation booths, and a panel of 12 professionals appropriately trained in cheese and dairy product evaluation, in accordance with standards NCh-ISO 5496:2016, 8586:2016, and 6658:2016.
This panel will be used to identify sensory descriptors of the milk samples using the Check-All-That-Apply (CATA) methodology.
Once the descriptors have been established, the panel will provide objective and descriptive information regarding the milk samples, including the intensity or presence of different sensory attributes such as appearance, texture, flavor, taste, and others.
Statistical Analysis
Before conducting the analyses, data distribution will be assessed using the Shapiro-Wilk test, and homogeneity of variances will be evaluated using the F-test.
To determine whether differences in GI and GR exist among the milk samples, analysis of variance (ANOVA) followed by Tukey's test or the Kruskal-Wallis test followed by Dunn's test will be used, depending on the distribution of the data.
Statistical significance will be established at p \< 0.05.
All analyses will be performed using SPSS version 20.0.
3,755 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.
This study's enrollment of 14 is below the median of 40 across 2,821 interventional studies indexed under Diabetes Mellitus, Type 1.
Browse Diabetes Mellitus, Type 1 studies →Pontificia Universidad Catolica de Chile is the lead sponsor of 225 studies on the registry; 59 are open to participants now.
Compared within Diabetes Mellitus, Type 1, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Diabetes Mellitus. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Inclusion Criteria: Individuals with type 1 diabetes.
Insulin pump users.
Age over 18 years.
No physical exercise during the 24 hours preceding the study.
No active insulin remaining from a previous bolus (participants must be fasting or must have eaten breakfast sufficiently early).
Exclusion Criteria:
Food allergies and/or intolerances to the products under study.
Poor glycemic control.
Gastrointestinal symptoms following food consumption.
Malabsorptive diseases (Crohn's disease or active celiac disease).
Short bowel syndrome.
The study included a single group of participants, all of whom consumed four different types of milk on separate study days. The order of administration was determined by individual participant preference, without randomization or predefined treatment sequences. Therefore, the Interventional Study Model has been revised to "Single Group Assignment" to accurately reflect the study procedures. The four milk types remain registered as separate interventions. Each arm can correspond to a milk: * Arm 1: Milk Type A * Arm 2: Milk Type B * Arm 3: Milk Type C * Arm 4: Milk Type D
Other: Milk Consumption (Cow's, Lactose-Free Cow's, Goat's, and Donkey's Milk).
Participants with type 1 diabetes will consume four different types of milk: regular cow's milk, lactose-free cow's milk, goat's milk, and donkey's milk. Each milk sample will provide an equivalent amount of available carbohydrates. Participants will consume one type of milk per week over four consecutive weeks, following an initial visit for informed consent, insulin pump validation, and study instructions. Capillary blood glucose levels will be measured before milk consumption and at 1, 3, and 4 hours post-consumption. Additionally, glucose levels will be monitored using the insulin pump sensor to assess postprandial glycemic responses over a 4-hour period. The intervention will be conducted over approximately 5 weeks per participant.
Glycemic Index
1\. Glycemic Index (GI): The glycemic index of regular cow's milk, lactose-free cow's milk, goat's milk, and donkey's milk in healthy individuals, determined by calculating the incremental area under the blood glucose response curve (iAUC) over a 2-hour period following consumption, relative to a glucose reference solution.
Time frame: Over a period of 6 weeks
Postprandial Glycemic Response
2\. Postprandial Glycemic Response (GR): Changes in blood glucose levels following the consumption of isoglucidic amounts of regular cow's milk, lactose-free cow's milk, goat's milk, and donkey's milk in individuals with type 1 diabetes, assessed through capillary blood glucose measurements and continuous glucose monitoring over a 4-hour period.
Time frame: Over a period of 6 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from May 2023 to primary completion in Nov 2024, 18 months.
Of 848 non-industry interventional studies with no phase under Diabetes Mellitus, Type 1, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's 18 months is close to that.
Counting every sponsor, half of 953 studies reached it within 18 months; a quarter within 9 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pontificia Universidad Catolica de Chile →